Veterinary Clnical Pathology

Please use this identifier to cite or link to this item: 192.168.6.56/handle/123456789/1751

Full metadata record

DC Field	Value	Language
dc.contributor.editor	P.Freeman, Kathleen	-
dc.date.accessioned	2018-09-17T07:57:54Z	-
dc.date.available	2018-09-17T07:57:54Z	-
dc.date.issued	2015	-
dc.identifier.isbn	978-1-4822-2590-7	-
dc.identifier.uri	http://10.6.20.12:80/handle/123456789/1751	-
dc.description	Anthrax essentially ceased to be regarded as a disease of major health or economic importance after the enormous successes of Max Sterne’s veterinary vaccine developed in the 1930s, and subsequent analogs in the former Soviet union, in dramatically reducing the incidence of the disease in livestock throughout the world in the ensuing two decades. the 1980s saw a resurgence of interest in the disease, partly stimulated by a renewed focus on Bacillus anthracis, the agent of anthrax, as a potential agent for a biological weapon, after the largest reported outbreak of human inhalational anthrax that took place in 1979 in the city then called Sverdlovsk (now ekaterinburg) in the former Soviet union, and partly because of increasing recognition that anthrax had by no means “gone away” as a naturally occurring disease in animals and humans in many countries	en
dc.language	en	en
dc.language.iso	en	en_US
dc.publisher	Taylor & Francis Group, LLC	en_US
dc.subject	pathology	en_US
dc.title	Veterinary Clnical Pathology	en_US
dc.type	Book	en_US
Appears in Collections:	Veterinary Medicine

Files in This Item:

File	Description	Size	Format
42,2015.pdf.pdf		10.96 MB	Adobe PDF	View/Open